LEADER 03465nam  2200733Ia 450 
001 9910972276903321
005 20251017110104.0
010   $a9786613081544
010   $a9780309211604
010   $a0309211603
010   $a9781283081542
010   $a1283081547
010   $a9780309160254
010   $a0309160251
035   $a(CKB)2550000000032929
035   $a(OCoLC)720652128
035   $a(CaPaEBR)ebrary10466013
035   $a(SSID)ssj0000536184
035   $a(PQKBManifestationID)11356867
035   $a(PQKBTitleCode)TC0000536184
035   $a(PQKBWorkID)10546124
035   $a(PQKB)11158635
035   $a(MiAaPQ)EBC3378768
035   $a(Au-PeEL)EBL3378768
035   $a(CaPaEBR)ebr10466013
035   $a(CaONFJC)MIL308154
035   $a(OCoLC)741449814
035   $a(Perlego)4739094
035   $a(DNLM)1563410
035   $a(EXLCZ)992550000000032929
100   $a20110405d2011      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 04$aThe emerging threat of drug-resistant tuberculosis in southern Africa $eglobal and local challenges and solution : summary of a joint workshop /$fby the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$dc2011
215   $a1 online resource (146 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311 08$a9780309160247 
311 08$a0309160243 
320   $aIncludes bibliographical references.
327   $aIntroduction -- The incidence of drug-resistant TB in South Africa -- Surveillance and tracking of drug-resistant TB -- Transmission and infection control -- Diganosis of drug-resistant TB -- Treatment of drug-resistant TB -- Drug-resistant TB in children -- Convergence of science and policy to create a blueprint for action.
330   $a"Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, Development, and Translation and the Academy of Science of South Africa held a workshop to discuss ways to fight the growing threat of drug-resistant TB."--Publisher's website.
606   $aMultidrug-resistant tuberculosis$xPrevention$zSouth Africa$vCongresses
606   $aTuberculosis$zSouth Africa$vCongresses
606   $aDrug resistance$vCongresses
615  0$aMultidrug-resistant tuberculosis$xPrevention
615  0$aTuberculosis
615  0$aDrug resistance
701   $aClaiborne$b Anne B$01805914
701   $aLebovitz$b Yeonwoo$01807991
701   $aOlson$b Steve$f1956-$0488724
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aAcademy of Science of South Africa.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910972276903321
996   $aThe emerging threat of drug-resistant tuberculosis in southern Africa$94358020
997   $aUNINA